Share this link via:
The Robotic Endoscopy Devices Market size was valued at around 2.87 billion in 2025 and is expected to reach a value of USD 5.99 billion by 2034, at a CAGR of 8.5% over the forecast period (2025–2034).
The global robotic endoscopy devices market is confronted with a tremendous boost due to the evolution of medical robotics, increased adoption of minimally invasive surgical procedures, and an increase in gastrointestinal, pulmonary, and urological disease cases. Robotic endoscopy devices integrate endoscopic technology and robotics to deliver precision, dexterity, and visualization to make diagnostic and therapeutic success even superior. These devices are now being used in hospitals, ambulatory surgery centres, and specialty clinics as they provide benefits including less procedural time, increased dexterity, and lower complications risks than traditional endoscopic techniques.
Technological improvements in the field of artificial intelligence (AI), machine learning, and three-dimensional (3D) imaging are compelling next-generation robotic endoscopy systems. Roeverballed by AI-guided navigation, and real-time image evaluation are increasing the precision, and the robotic-controlled help the surgeon performs complicated operations with minimal tremors and improved accuracy. Growing demand for automation of surgical procedures is also propelling the use of robotic endoscopy, especially in cases such as colorectal cancer screening, bronchoscopy, and intra-abdominal procedures. Furthermore, inclusion of haptic feedback and remote-control features is increasing the ease of use of robotic endoscopy systems, with improved ergonomics and reduced physician fatigue.
The increasing prevalence of chronic conditions such as gastrointestinal cancers, inflammatory bowel diseases, and gastroesophageal reflux disease (GERD) is one of the principal drivers propelling market growth. The increasing number of aged populations, which are susceptible to such conditions, is also augmenting the need for advanced endoscopic interventions. The shift towards value-based healthcare and outpatient preference have pushed the demand for robotic endoscopy because the technology offers improved patient outcomes with reduced hospital stays and faster recovery times.
Despite the positive outlook, the market is confronted with the expense of robotic endoscopy systems and the requirement for specialized training for medical professionals. The initial investment and maintenance cost of robotic systems can be prohibitive, dampening adoption in cost-sensitive healthcare settings. Concerns over device reliability, regulatory approval procedures, and reimbursement policies remain major drivers of market growth. However, steady R&D activities, collaborative measures between healthcare organizations and medical device firms, and increasing investments for robotic-assisted medical devices will probably overcome such obstacles and facilitate market growth.
The competition in the market of robotic endoscopy devices is transforming, with industry leaders focusing on innovation, product approvals, and strategic partnerships to strengthen their positions in the market. Organizations are investing in robotic platforms powered by AI, cloud-based data integration, and high-end imaging solutions to improve procedural efficiency and clinical results. Further, growing mergers and acquisitions in the medical robotics segment are facilitating enhanced robotic endoscopy capabilities. With increasing demands for minimally invasive procedures, the market is expected to continue growing due to sustained technological advancement and greater emphasis on precision medicine in endoscopic diagnosis and therapy.
The market scope is segmented because of by Product, by Application, by End-use.
Based on the Product of the market is segmented into Diagnostic, Therapeutic.
The therapeutic segment led the market for robotic endoscopy devices globally, mainly because of the growing demand for minimally invasive robotic-assisted surgical procedures in all medical specialties. Robotic endoscopy is extensively applied in therapeutic procedures like polyp removal, tumour resection, and other gastrointestinal, urological, and pulmonary interventions. The accuracy potential of robotic-assisted systems in terms of better precision, reducing procedural risk, and providing better patient outcomes has been responsible for its growing application in therapeutic procedures. Application of other technologies like AI-aided navigation, 3D imaging, and haptic feedback has also bettered accuracy and effectiveness of robotic therapeutic endoscopic procedures.
The increasing incidence of chronic diseases, especially gastrointestinal cancers, inflammatory bowel disease, and gastroesophageal reflux disease (GERD), has also boosted the demand for robotic-assisted therapeutic interventions. The preference for minimally invasive procedures, which ensure reduced hospitalization stays, quicker recovery rates, and fewer complications, has also contributed to the overall dominance of this segment.
Explosive rise of robotic surgical programs in healthcare organizations and ambulatory surgical facilities coupled with supportive reimbursement policies within mature economies have supported the progression of therapeutic robotic endoscopy. Although growth of the diagnostic segment is forthcoming driven by an expanding demand for timely detection of the disease, development of image-imaging products reliant on Artificial Intelligence, growth is also provided for the therapeutical segment in view of a larger scale of clinical indications along with stronger incorporation in developed advanced, low-precision procedure-based methods.
Based on the Application of the market is segmented into Laparoscopy, Bronchoscopy, Colonoscopy, Others.
Colonoscopy dominated the market for robotic endoscopy equipment globally, driven by the rising incidence of colorectal cancer and other gastrointestinal diseases requiring advanced diagnostic and therapeutic care. Robotic colonoscopy has significant advantages over conventional methods in terms of improved manoeuvrability, increased visualization, and greater precision in detecting and excising polyps. The increasing demand for minimally invasive surgery, combined with the increased focus on cancer prevention and early detection, has prompted the extensive use of robotic colonoscopy systems.
The rising number of cases of colorectal cancer in the latter, especially in North America and Europe, has been followed by a rise in screening campaigns and, as such, a surge in robotic-assisted colonoscopy adoption. The development of artificial intelligence (AI)-enhanced robotic technology has also raised the detection rates for polyps and the efficiency of procedures, making the colonoscopy process more accurate and effective. The increasing trend towards outpatient and ambulatory care environments has also driven the growth of robotic colonoscopy, as these devices allow for quicker recovery periods and lower hospitalization rates.
By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America led the world robotic endoscopy devices market, largely because of the region's highly developed healthcare infrastructure, high uptake of sophisticated medical technologies, and heavy investments in robotic-assisted surgical systems. The availability of major market players, favourable reimbursement policies, and growing demand for minimally invasive procedures have also helped the region lead. The increasing incidence of gastrointestinal diseases, colorectal cancer, and lung disease has helped in the increase in demand for robotic endoscopic procedures, especially in America. The expansion of artificial intelligence and machine learning implementation in robotics solutions and government efforts to encourage innovation in healthcare have helped in increasing the market share of North America.
Asia-Pacific would be the growth leader in the robotic endoscopy devices market, driven by increasing expenditure on healthcare, heightened awareness of advanced medical technology, and rising gastrointestinal disease burden. The demographic bulge in the region, particularly in China, Japan, and India, has generated mounting demand for less-invasive interventions. Additionally, speedy developments in healthcare infrastructure, government initiatives favouring medical robots, and rising investments by international medical device manufacturers in the Asia-Pacific region are propelling market growth. Availability of a huge pool of patients and growing numbers of hospitals with robotic-assisted surgical systems are also driving the growth in robotic endoscopy in the region. As economic growth continues and healthcare accessibility improves, Asia-Pacific is poised to witness the highest adoption rates, making it the fastest-growing market for robotic endoscopy devices.
In March 2024, The FDA cleared Intuitive Surgical's da Vinci 5, a next-generation multiport robotic system. The da Vinci 5 is a significant advance in surgical technology, leveraging the tried-and-true foundation of the da Vinci Xi, which has been utilized in over 7 million procedures worldwide.
In December 2023 Cosmo Intelligent Medical Devices and Medtronic joined forces to declare a strategic partnership. Development of the GI Genius intelligent endoscopy module a tool meant to enhance clinical outcomes and patient care was at the forefront of this union. Both companies expressed their collective commitment to utilizing AI technology in developing innovative medical devices that will improve patient outcomes.
The report will cover the qualitative and quantitative data on the global Robotic Endoscopy Devices Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Study Period | 2025-33 |
Base Year | 2024 |
Estimated Forecast Year | 2025-33 |
Growth Rate | CAGR of 8.5% from 2025 to 2033 |
Segmentation | By Product, By Application, By End-use, By Region |
Unit | USD Billion |
By Product |
|
By Application |
|
By End-use |
|
By Region |
|
North America accounted for the highest xx% market share in terms of revenue in the Robotic Endoscopy Devices market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Robotic Endoscopy Devices. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Robotic Endoscopy Devices companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global Robotic Endoscopy Devices Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Robotic Endoscopy Devices Market Report is also available for below Regions and Country Please Ask for that
Robotic Endoscopy Devices Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends:
You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-
+1 724 648 0810 +91 976 407 9503 sales@intellectualmarketinsights.com
20 Jun 2022